Sanofi provides update on Kevzara® (sarilumab) Phase 3 trial in severe and critically ill COVID-19 patients outside the U.S.

Brenda Snow
Authentic Patient Voice

Matthew Durham
Omnidynamic Marketing

Joey Cohen
Medication Adherence

Amy Giles
Increasing Engagement

Pat Purcell
Meeting Engagement

Bud Bilanich
Success Coach

David Linetsky
Point-of-Care Marketing

Daniel Sontupe
Market Access

Liz Kane
Impactful Strategy

Paul Theisen
Patient Acquisition

Matt Turner
Patient Affordability

Suma Ramadas, PhD
Medical Affairs

Stacey Gandler
Brand Nourishment

Frank Burrell
Scientific Storytelling